CLOPIDOGREL VERSUS NOVEL P2Y12 INHIBITOR USE IN FIBRINOLYSIS TREATED ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)

Autor: Dehghani, P., Tan, M.K., Mehta, S.R., Fisher, H.N., Cantor, W.J., Cheema, A.N., Dery, J., Welsh, R.C., Lavi, S., Kokis, A., Cieza, T., Ducas, J., Kassam, S.A., Brass, N., Kim, H., Fung, A., Wang, T., Bagai, A., Goodman, S.G.
Zdroj: In Canadian Journal of Cardiology October 2016 32(10) Supplement 1:S116-S117
Databáze: ScienceDirect
Externí odkaz: